Market Overview

Benzinga's Top Pre-Market Gainers

Related LXRX
Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care
Benzinga's Top Downgrades
Related TEVA
Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca
Notable Hedge Funds Disclose Additions And Reductions To Holdings
Sofinnova Ventures Closes $500M Fund (Fox Business)

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 21.99% to $2.33 in the pre-market session. Lexicon Pharmaceuticals reported positive results of LX4211 Phase 2b trial for type 2 diabetes.

Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) added 6.87% to $40.62 in the pre-market session. Teva reported favorable court ruling in COPAXONE® patent infringement litigation.

Watson Pharmaceuticals (NYSE: WPI) moved up 2.37% to $72.70 in the pre-market session. Watson Pharmaceuticals entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion..

SanDisk (NASDAQ: SNDK) soared 1.35% to $36.85 in the pre-market trading. Analysts at Goldman Sachs upgraded SanDisk from “neutral” to “buy.”

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (LXRX + SNDK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters